Product Detail

Name: Semaglutide   Feature:  It is a long-acting dosage form developed based on the basic structure of Lilalutide, and has better effect in treating type 2 diabetes. Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217) is a long-acting glucagon like peptide 1 (GLP-1) analog, an activator of GLP-1 receptor, and has potential therapeutic effect on type 2 diabetes (T2DM).   Composition: Assay: 99% Appearance: White powder CAS No. 910463-68-2 Packing: 25kg Shelf Life: 2 years Storage: Store in cool and dry area Certification:ISO.